Buse Kent, Tanaka Sonja, Hawkes Sarah
UNAIDS, Geneva, Switzerland.
, Paris, France.
Global Health. 2017 Jun 15;13(1):34. doi: 10.1186/s12992-017-0255-3.
Non-communicable diseases (NCDs) represent a significant threat to human health and well-being, and carry significant implications for economic development and health care and other costs for governments and business, families and individuals. Risks for many of the major NCDs are associated with the production, marketing and consumption of commercially produced food and drink, particularly those containing sugar, salt and transfats (in ultra-processed products), alcohol and tobacco. The problems inherent in primary prevention of NCDs have received relatively little attention from international organizations, national governments and civil society, especially when compared to the attention paid to secondary and tertiary prevention regimes (i.e. those focused on provision of medical treatment and long-term clinical management). This may in part reflect that until recently the NCDs have not been deemed a priority on the overall global health agenda. Low political priority may also be due in part to the complexity inherent in implementing feasible and acceptable interventions, such as increased taxation or regulation of access, particularly given the need to coordinate action beyond the health sector. More fundamentally, governing determinants of risk frequently brings public health into conflict with the interests of profit-driven food, beverage, alcohol and tobacco industries.
We use a conceptual framework to review three models of governance of NCD risk: self-regulation by industry; hybrid models of public-private engagement; and public sector regulation. We analyse the challenges inherent in each model, and review what is known (or not) about their impact on NCD outcomes.
While piecemeal efforts have been established, we argue that mechanisms to control the commercial determinants of NCDs are inadequate and efforts at remedial action too limited. Our paper sets out an agenda to strengthen each of the three governance models. We identify reforms that will be needed to the global health architecture to govern NCD risks, including to strengthen its ability to consolidate the collective power of diverse stakeholders, its authority to develop and enforce clear measures to address risks, as well as establish monitoring and rights-based accountability systems across all actors to drive measurable, equitable and sustainable progress in reducing the global burden of NCDs.
非传染性疾病对人类健康和福祉构成重大威胁,对经济发展以及政府、企业、家庭和个人的医疗保健及其他成本产生重大影响。许多主要非传染性疾病的风险与商业生产的食品和饮料的生产、营销及消费有关,特别是那些含有糖、盐和反式脂肪(超加工产品中)、酒精和烟草的产品。非传染性疾病一级预防中固有的问题相对较少受到国际组织、国家政府和民间社会的关注,尤其是与对二级和三级预防机制(即侧重于提供医疗治疗和长期临床管理的机制)的关注相比。这可能部分反映出直到最近非传染性疾病在全球总体卫生议程中都未被视为优先事项。政治优先级较低也可能部分归因于实施可行且可接受的干预措施(如提高税收或规范获取途径)所固有的复杂性,特别是考虑到需要在卫生部门之外协调行动。更根本的是,管控风险决定因素往往使公共卫生与追求利润的食品、饮料、酒精和烟草行业的利益发生冲突。
我们使用一个概念框架来审视非传染性疾病风险的三种治理模式:行业自我监管;公私合作的混合模式;以及公共部门监管。我们分析每种模式中固有的挑战,并审视关于它们对非传染性疾病结果的影响已知(或未知)的情况。
虽然已经做出了一些零散的努力,但我们认为控制非传染性疾病商业决定因素的机制并不充分,补救行动的力度也过于有限。我们的论文提出了加强这三种治理模式的议程。我们确定了全球卫生架构治理非传染性疾病风险所需的改革,包括加强其整合不同利益相关者集体力量的能力、制定和执行明确的风险应对措施的权威,以及为所有行为体建立监测和基于权利的问责制度,以推动在减轻全球非传染性疾病负担方面取得可衡量、公平和可持续的进展。